KALA M&A Thursday, September 10, 2026 +0.50 Positive

KALA enters exclusive sales agreement with Virotek

Kala Bio, Inc. is entering an exclusive distribution and reseller agreement with Virotek Inc. to market ophthalmology genomic testing services in a designated territory.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day